Category: PSYCH NEWS

Johns Hopkins Receives $20M From Roland R. Griffiths Ph.D. Professorship Fund For Psychedelic Research

John Hopkins Center for Psychedelic and Consciousness Research Johns Hopkins University academics just a got a boost in their funding thanks to the recently launched Roland R. Griffiths Ph.D. Professorship Fund.

PSYCHECEUTICAL TO CONDUCT THE FIRST EVER PHASE I AND II CLINICAL TRIALS OF A NOVEL KETAMINE TOPICAL CREAM TO TREAT PTSD

Psycheceutical ​​enters into agreement with iNGENū to conduct ​human ​clinical trials of NeuroDirect™ ketamine topical ​in Australia Phase I trial will study 20 people to...

Stressed Wall Street Execs Flock to Ketamine Therapy Sessions (NY Post)

Therapy’s a trip for these Wall Street executives. Wealthy stock traders are flocking to a Manhattan-based ketamine therapy practice that doles out the hallucinogenic drug in a lavish setting to...

‘Magic Mushroom’ Psychedelic may Help Heavy Drinkers Quit (AP News)

Psychedelic Drug Helped People with Alcohol use Disorder Reduce Drinking, Study Shows (Today) Psilocybin, the ingredient in magic mushrooms, along with talk...

Ehave, Inc. Announces its KetaDASH Mobile Unit Delivered to Miami Beach.

MIAMI, June 03, 2022 (GLOBE NEWSWIRE) -- Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a leading healthcare services and technology company, announced today its KetaDASH subsidiary will accept delivery of...

Coming This Monday

Microdose’s Wonderland: Miami Conference to be held at the Adrienne Arsht Center for the Performing Arts in Miami, FL on November 7-9, 2021. Wonderland: Miami

Interview: Great Interview With Cybin (CYBN) CEO Doug Drysdale.

https://youtu.be/JXNEmACes2U?t=605 Interview start at 10:00 mark. LIVE QUOTE It had been a long descent lower for AdvisorShares...

Ehave (EHVVF) Announces Inclusion in the 2021 Psychedelic Investor Guide

MIAMI, Sept. 27, 2021 (GLOBE NEWSWIRE) — Ehave, Inc., (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today that it...
Most Popular

Interview: Dr. Deborah Nash, Ibogaine and Miami Based DemeRX.

Partnered with ATAI Life Sciences ATAI. Amazing Interview. "I said there's no way that you can take one dose of Ibogaine...

Psychedelic Marketing: Adrian Morrison

https://youtu.be/EZPAoTFqaro

Shark Tank’s Kevin Harrington Invests In Psychedelics Company Psycheceutical (BWVI). Forbes

Mike Zapolin, Kevein Harrington and CEO Chad Harman Another Shark Tank original has invested in the psychedelic industry.